Resources

Table. Recommended doses and intervals between doses for human papillomavirus (HPV) vaccines, by age group at the start of the course

Age group	Recommended doses	Recommended schedule	Notes
Starting HPV vaccination at 9–14 years of age (except people who are immunocompromised)	2	0, 6–12 months	The recommended age for HPV vaccination is 12–13 years, but people can receive vaccines from 9 years of age. If a person has received 2 doses of HPV vaccine with an interval of <5 months between dose 1 and dose 2, they need a 3rd dose at least 12 weeks after the 2nd dose. Ensure that the minimum intervals for 3 doses are met. If the 2nd dose is received <6 months but ≥5 months after the 1st dose, a 3rd dose is not required; clinical trial data support this interval still being sufficiently immunogenic.
Starting HPV vaccination at ≥15 years of age	3	0, 2, 6 months	A 3-dose schedule of 0, 1 and 6 months for (2-valent HPV) vaccine is acceptable.
People who are immunocompromised at any age (excluding those with asplenia or hyposplenia)	3	0, 2, 6 months	A 3-dose schedule of 0, 1 and 6 months for vaccine is acceptable.

Last updated:

5 June 2018

Last reviewed:

5 June 2018

Definitions

2vHPV: bivalent HPV vaccine

Is there anything wrong with this page?

All Handbook tables

Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/resources/handbook-tables/table-recommended-doses-and-intervals-between-doses-for-human.